PODD News and Press, Insulet Corporation From 05/08/25

2025-05-08 22:35:46 ET More on Insulet Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript Insulet Leans Bullish (Technical Analysis) Insulet: Aiding Patients And Investors Insulet Non-GAAP EPS of $1.02 beats by $0.23, revenue of $569M beats by $25.7M...

2025-05-08 16:32:41 ET More on Insulet Insulet Leans Bullish (Technical Analysis) Insulet: Aiding Patients And Investors Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript Insulet Q1 2025 Earnings Preview Insulet names new CEO, plans to lift ...

Raising Full Year Revenue and Gross Margin Guidance Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended Marc...

Ironwood Pharmaceuticals Inc. (IRWD) is expected to report $-0.05 for Q1 2025 CaliberCos Inc. (CWD) is expected to report $-0.4 for Q1 2025 BlackRock TCP Capital Corp. (TCPC) is expected to report $0.34 for Q1 2025 INmune Bio Inc. (INMB) is expected to report $-0.43 for Q1 2025 No...

2025-05-07 17:20:39 ET More on Insulet Insulet Leans Bullish (Technical Analysis) Insulet: Aiding Patients And Investors Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript Insulet names new CEO, plans to lift full year guidance Barclays names...

2025-05-07 04:55:00 ET Summary Fidelity® Select Health Care Portfolio employs a sector-based, equity-focused strategy, leveraging fundamental, bottom-up research to build a diversified portfolio of health care companies. The fund underperformed the MSCI health care index in Q...

2025-04-29 21:30:00 ET Summary IT sector convertibles remained a core fund focus, at 21.03% of total net assets at quarter-end, and were a notable area of weakness. US and global convertible bonds advanced in January and February 2025 before backtracking somewhat in March. In ...

2025-04-28 06:08:31 ET More on Insulet Insulet Leans Bullish (Technical Analysis) Insulet: Aiding Patients And Investors Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript Barclays names most and least affected MedTech companies from tariffs ...

Expects to Exceed First Quarter Revenue Guidance and Raise Full Year 2025 Guidance Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today an...

2025-04-16 13:04:12 ET More on Abbott Laboratories, Alphatec, etc. Abbott Laboratories (ABT) Q1 2025 Earnings Call Transcript Examination Of Alphatec Holdings: Prognosis--Chronic Cash Burn Johnson & Johnson (JNJ) Q1 2025 Earnings Call Transcript Abbott si...